In an RCT that enrolled 46 patients with COVID-19-associated pneumonia, the NAC (1,200–1,500 mg IV)-treated group showed a significant increase in blood oxygen saturation and CRP values and a decrease in hospital stay [36]. Here, CRP is linked to susceptibility to pneumonia measurement.